247 related articles for article (PubMed ID: 9369420)
1. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis.
Xerri L; Devilard E; Hassoun J; Haddad P; Birg F
Leukemia; 1997 Nov; 11(11):1868-77. PubMed ID: 9369420
[TBL] [Abstract][Full Text] [Related]
2. Fas ligand is not constitutively expressed in low-grade B-cell lymphoma and B-lymphoblastoid cells.
Grüllich C; Richter M; Exner S; Finke J
Eur J Haematol; 2003 Sep; 71(3):184-8. PubMed ID: 12930319
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient, in-vivo Fas-mediated apoptosis of B-cell lymphoma by hexameric CTLA4-FasL.
Aronin A; Amsili S; Prigozhina TB; Tzdaka K; Shen R; Grinmann L; Szafer F; Edebrink P; Rauvola MA; Shani N; Elhalel MD
J Hematol Oncol; 2014 Sep; 7():64. PubMed ID: 25227919
[TBL] [Abstract][Full Text] [Related]
4. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
8. Expression of Fas and Fas ligand in Hodgkin's disease.
Metkar SS; Naresh KN; Redkar AA; Soman CS; Advani SH; Nadkarni JJ
Leuk Lymphoma; 1999 May; 33(5-6):521-30. PubMed ID: 10342579
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
[TBL] [Abstract][Full Text] [Related]
10. CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway.
Vekemans K; Timmers M; Vermijlen D; De Zanger R; Wisse E; Braet F
Liver Int; 2003 Aug; 23(4):283-93. PubMed ID: 12895269
[TBL] [Abstract][Full Text] [Related]
11. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.
Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R
Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605
[TBL] [Abstract][Full Text] [Related]
12. HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand.
Noraz N; Gozlan J; Corbeil J; Brunner T; Spector SA
AIDS; 1997 Nov; 11(14):1671-80. PubMed ID: 9386801
[TBL] [Abstract][Full Text] [Related]
13. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
Dotti G; Savoldo B; Pule M; Straathof KC; Biagi E; Yvon E; Vigouroux S; Brenner MK; Rooney CM
Blood; 2005 Jun; 105(12):4677-84. PubMed ID: 15713795
[TBL] [Abstract][Full Text] [Related]
14. The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas.
Gutierrez LS; Eliza M; Niven-Fairchild T; Naftolin F; Mor G
Breast Cancer Res Treat; 1999 Apr; 54(3):245-53. PubMed ID: 10445423
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
[TBL] [Abstract][Full Text] [Related]
16. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
17. Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action.
Belanger AJ; Scaria A; Lu H; Sullivan JA; Cheng SH; Gregory RJ; Jiang C
Cardiovasc Res; 2001 Sep; 51(4):749-61. PubMed ID: 11530108
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of Fas ligand gene in human non-Hodgkin lymphoma.
Kim HS; Lee SH; Lee JW; Soung YH; Lee JH; Park JY; Cho YG; Kim CJ; Kim SY; Lee YS; Park WS; Kim SH; Lee JY; Yoo NJ
APMIS; 2003 Apr; 111(4):490-6. PubMed ID: 12780524
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
[TBL] [Abstract][Full Text] [Related]
20. FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis.
Xerri L; Devilard E; Bouabdallah R; Stoppa AM; Hassoun J; Birg F
Br J Haematol; 1999 Sep; 106(3):652-61. PubMed ID: 10468853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]